Form D · Biotechnology
Deepcell, Inc.
Menlo Park, CA · CIK 0001726075
Offering snapshot reported Oct 17, 2022 · SEC filing
- Reported sold
- $73M Offering amount: $80M
- Investors reported
- 16 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 6, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 17, 2022 | Initial | $72,950,699 | No comparison | 16 | SEC filing |
| Oct 14, 2022 | Initial | $19,993,472 | No comparison | 9 | SEC filing |
| Dec 28, 2017 | Initial | $3,999,998 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-461853
This filing covers the sale and purchase of Series B Preferred Stock, and the Common Stock issuable upon conversion thereof.
Source: Form D, filed Oct 17, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Euan Ashley | Director, Promoter |
| Blake Goodner | Director |
| Mahdokht Masaeli | Director, Executive, Promoter |
| David Mauney | Director |
| Matt Posard | Director |
| Mahyar Salek | Director, Executive, Promoter |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
4025 Bohannon Drive
Menlo Park, CA, 94025
Menlo Park, CA, 94025